Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-044710
Filing Date
2019-08-08
Accepted
2019-08-08 07:31:43
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10365_110q.htm 10-Q 1081061
2 EX-31.1 a19-10365_1ex31d1.htm EX-31.1 15646
3 EX-31.2 a19-10365_1ex31d2.htm EX-31.2 15854
4 EX-32.1 a19-10365_1ex32d1.htm EX-32.1 7040
  Complete submission text file 0001104659-19-044710.txt   4672850

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20190630.xml EX-101.INS 1066196
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20190630.xsd EX-101.SCH 35507
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20190630_cal.xml EX-101.CAL 40009
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20190630_lab.xml EX-101.LAB 329502
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20190630_pre.xml EX-101.PRE 225780
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20190630_def.xml EX-101.DEF 101748
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 191007479
SIC: 2834 Pharmaceutical Preparations